Free Trial
NASDAQ:FEED

Nanovibronix Q4 2025 Earnings Results & Report

Nanovibronix logo
$0.28 -0.03 (-8.26%)
As of 11/10/2026 02:27 PM Eastern

Nanovibronix reported Q4 2025 earnings on April 15, 2026. The company reported EPS of -$240.00, while revenue was $312 thousand.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
After Market Closes

Nanovibronix EPS Results

Actual EPS
-$240.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nanovibronix Revenue Results

Actual Revenue
$312 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Nanovibronix Q4 2025 Earnings FAQ

Nanovibronix (NASDAQ:FEED) reported earnings of -$240.00 per share for Q4 2025. The report was announced on Wednesday, April 15, 2026.

Nanovibronix reported revenue of $312 thousand for Q4 2025.

Nanovibronix Earnings Headlines

ENvue Medical Issues Letter to Shareholders
ENvue Medical Provides Nasdaq Listing Update
My prediction for December 8th
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
FEED Share News Today
See More Nanovibronix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nanovibronix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nanovibronix and other key companies, straight to your email.

About Nanovibronix

Nanovibronix (NASDAQ:FEED) is a medical device company focused on developing and commercializing noninvasive therapeutic ultrasound products. Its technology is designed to deliver low-intensity ultrasound through the skin for applications involving pain management, wound care and other therapeutic needs.

The company’s product portfolio has included PainShield, a wearable ultrasound device intended to provide localized relief for chronic and acute pain, and WoundShield, a device designed to support the treatment of chronic and difficult-to-heal wounds. NanoVibronix has marketed its products through healthcare providers, distributors and direct-to-consumer channels.

NanoVibronix has operated in the United States and international markets, including through distribution relationships in Europe and other regions. Public references generally identify NanoVibronix under the ticker symbol NAOV; the symbol FEED does not appear to correspond to the company.

View Nanovibronix Profile